MoneyWorks4Me

Windlas Biotech - Quaterly Results

08 Feb 2023 Evaluate
The quarter ended December 2022 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1197.04 millions.Net profit stood at Rs. 91.88  millions  compared to Rs. 83.15 millions in the corresponding previous quarter,high by 10.50%.Operating profit for the quarter ended December 2022 rose to 161.11 millions as compared to 148.36 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1197.04 1175.91 1.80 3723.70 3437.99 8.31 4659.30 4276.02 8.96
Other Income 21.62 17.93 20.58 76.31 37.01 106.19 67.06 30.94 116.74
PBIDT 161.11 148.36 8.59 514.31 423.11 21.55 596.01 577.86 3.14
Interest 1.57 2.11 -25.59 6.22 11.29 -44.91 14.17 12.90 9.84
PBDT 159.54 146.25 9.09 508.09 411.82 23.38 581.84 241.45 140.98
Depreciation 31.35 31.45 -0.32 87.96 92.45 -4.86 121.47 129.65 -6.31
PBT 128.19 114.80 11.66 420.13 319.37 31.55 460.37 111.80 311.78
TAX 36.31 31.65 14.72 108.16 86.09 25.64 74.76 61.70 21.17
Deferred Tax 8.65 4.12 109.95 6.75 1.93 249.74 -26.57 13.28 -300.08
PAT 91.88 83.15 10.50 311.97 233.28 33.73 385.61 50.10 669.68
Equity 107.21 108.97 -1.62 108.97 108.97 0.00 108.97 64.11 69.97
PBIDTM(%) 13.46 12.62 6.68 13.81 12.31 12.23 12.79 13.51 -5.34
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..